Value of in-house viral transport medium in breaking the bottlenecks for viral testing in Pakistan
DOI:
https://doi.org/10.61529/idjp.v33i4.322Abstract
Background: Maintenance of a steady supply of viral transport medium (VTM) for transporting clinical samples to the laboratory for viral testing is critical amid periods of viral outbreak. Hence, we prepared an in-house VTM and validated its capacity to preserve viral nucleic acids.
Material and Methods: We used Phosphate-buffered saline (PBS) supplemented with sterile glycerol and a combination of antibiotics viz. vancomycin, colistin sulphate, amphotericin B and trimethoprim lactate, for our VTM formulation. For stability, antimicrobial efficacy and sterility evaluation, representative samples from each batch were selected. To validate our VTM, we tested clinical nasal swab samples transported in commercially available (Copan Italia S.p.A.) and in-house VTM, and compared both the media for viral nucleic acid recovery using Reverse transcriptase-polymerase chain reaction (RT-PCR).
Results: A satisfactory evaluation of in-house VTM in terms of stability, antimicrobial efficacy and sterility was obtained. A total of 239 nasal swab samples were processed in both commercial and PBS VTM, of which 61 (25.5%) transported in commercial VTM were positive compared to 63 (26.4%) transported in PBS VTM. A comparison of Ct values in RT-PCR positive samples from both groups (n=61), showed Ct values of less than 25 in 14.7% samples from PBS VTM compared to 21.3% from commercial VTM. Whereas, more samples from PBS VTM (78.7%) compared to commercial VTM (73.8%) exhibited Ct values of more than 30. Our results showed that PBS VTM exhibited 100% sensitivity, 98.9% specificity, 96.8% positive predictive value and 100% negative predictive value.
Conclusion: Our in-house prepared VTM was successfully validated and offers a readily available, cost-effective, and simpler to prepare alternative for diagnostic laboratories in low resource settings.
Keywords: Viral transport medium, VTM, Viruses, RT-PCR
References
Naseem Z, Ayub M, Shah SA, Ali SA, Abidi SH. Viral infections in Pakistan: Prevalence, factors affecting spread, and recommendations for control. J Infect Dev Ctries. 2022;16(6):913–26. DOI: http://dx.doi.org/10.3855/jidc.15078
Salman M, Badar N, Ikram A, Nisar N, Farooq U. Estimation of seasonal influenza disease burden using sentinel site data in Pakistan 2017-2019: A cross-sectional study. Influenza Other Respi Viruses. 2023;17(3): e13125. DOI: http://dx.doi.org/10.1111/irv.13125
Masood I, Tahir MJ, Naeem A, Shrateh ON, Ahmed A. The new wave of Congo virus in Pakistan: emerging threat. Trop Med Health. 2023; 51(1): 62. DOI: http://dx.doi.org/10.1186/s41182-023-00559-z
Waseem S, Shaikh TG, Ahmed SH, Usama RM, Asghar MS, Tahir MJ. West Nile virus outbreak in Pakistan: Another potential public health threat in the pipeline? Ann Med Surg (Lond). 2022; 77(103663): 103663. DOI: http://dx.doi.org/10.1016/j.amsu.2022.103663
Rehman K. Potential Chikungunya epidemics in Pakistan: Act before it’s too late. J Ayub Med Coll Abbottabad. 2019; 31(3): 474–5. Available from: https://jamc.ayubmed.edu.pk/jamc/index.php/jamc/article/view/4453/2755
Manan MR, Nawaz I, Zafar F. Uncovering the mosaic of emerging infections: The threat of Japanese encephalitis virus in Pakistan. Trop Doct. 2023; 53(4): 410–1. DOI: http://dx.doi.org/10.1177/00494755231178946
Litwin T, Timmer J, Berger M, Wahl-Kordon A, Müller MJ, Kreutz C. Preventing COVID-19 outbreaks through surveillance testing in healthcare facilities: A modelling study. BMC Infect Dis. 2022; 22(1): 105.
DOI: http://dx.doi.org/10.1186/s12879-022-07075-1
Petersen J, Dalal S, Jhala D. Criticality of in-house preparation of viral transport medium in times of shortage during COVID-19 pandemic. Lab Med. 2021; 52(2): e39–45. DOI: http://dx.doi.org/10.1093/labmed/lmaa099
Khalid A, Ali S. COVID-19 and its challenges for the healthcare system in Pakistan. Asian Bioeth Rev. 2020; 12(4): 551–64. DOI: http://dx.doi.org/10.1007/s41649-020-00139-x
Mouza census 2020 [cited 2024 Jan 9]. Available from: https://www.pbs.gov.pk/content/mouza-census-2020
Cdc.gov [cited 2024 Jun 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/downloads/Viral-Transport-Medium.pdf
Razu MH, Monir BB, Moniruzzaman M, Sarkar S, Akhter S, Kamal S, et al. Performance evaluation of SARS-CoV-2 viral transport medium produced by Bangladesh reference institute for chemical measurements. Diagnostics (Basel). 2023; 13(9). DOI: http://dx.doi.org/10.3390/diagnostics13091622
Fang CY, Wu CC, Fang CL, Chen WY, Chen CL. Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines. PLoS One. 2017; 12(6): e0178960. DOI: http://dx.doi.org/10.1371/journal.pone.0178960
Rodino KG, Espy MJ, Buckwalter SP, Walchak RC, Germer JJ, Fernholz E, et al. Evaluation of saline, phosphate-buffered saline, and minimum essential medium as potential alternatives to viral transport media for SARS-CoV-2 testing. J Clin Microbiol. 2020; 58(6). DOI: http://dx.doi.org/10.1128/JCM.00590-20
Rogers AA, Baumann RE, Borillo GA, Kagan RM, Batterman HJ, Galdzicka MM, et al. Evaluation of transport media and specimen transport conditions for the detection of SARS-CoV-2 by use of real-time reverse transcription-PCR. J Clin Microbiol. 2020; 58(8). DOI: http://dx.doi.org/10.1128/JCM.00708-20
Pakistan bureau of statistics [cited 2024 Jan 9]. Available from: https://www.pbs.gov.pk/census-2017-district-wise/results/096
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Fareeha Adnan, Nazia Khursheed, Moiz Khan, Maira Khan, Nazia Parveen, Marium Khan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.